MPW - NYSE

Medical Properties Trust, Inc.

MPW·NYSE

$5.36

+1.5%

Real EstateREIT - Healthcare Facilities

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$3.22B

EPS-4.0200

P/E Ratio-1.33

Earnings Date02/26/2026

14.29B

Assets

-22%

3Y-30.0%

5Y-1.0%

10Y+155.0%

9.46B

Total Liabilities

-11%

3Y-22.0%

5Y+27.0%

10Y+170.0%

4.83B

Total Equity

-37%

3Y-43.0%

5Y-31.0%

10Y+129.0%

Medical Properties Trust, Inc. Funding & Solvency Profile

MPW · NYSE

Current Assets

Cash & Cash Equivalents332.33M

Net Receivables846.28M

Inventory0.00

Other Current Assets0.00

Total Current Assets1 B

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets0.00

Long-Term Investments1.60B

Other Non-Current Assets11.38B

Total Non-Current Assets13 B

Total Assets

14.29B

Financial Health Analysis

Current Ratio

1.55x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.96x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

468 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

9% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Medical Properties Trust, Inc. Balance Sheet

MPW • NYSE

Medical Properties Trust, Inc. Balance Sheet	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006	Dec 2005
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	332.3M	250M	235.7M	459.2M	549.9M	1.5B	820.9M	171.5M	83.2M	195.5M	144.5M	46M	37.3M	102.7M	98.4M	15.3M	11.7M	94.2M	4.1M	59.1M
Cash & Short-Term Investments	332.3M	250M	235.7M	459.2M	549.9M	1.5B	820.9M	171.5M	83.2M	195.5M	144.5M	46M	37.3M	102.7M	98.4M	15.3M	11.7M	94.2M	4.1M	59.1M
Net Receivables	846.3M	973.7M	1.2B	2.8B	2.5B	2.4B	246.7M	264.6M	174.6M	129.1M	539.8M	265.4M	81.1M	63.9M	55.1M	47.4M	32.8M	34M	24.6M	9.5M
Accounts Receivables	737.1M	681M	954.2M	2.8B	2.5B	2.4B	246.7M	264.6M	174.6M	129.1M	539.8M	265.4M	81.1M	63.9M	28.9M	27.5M	32.8M	25.1M	0.0	0.0
Other Receivables	109.2M	292.6M	227.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6M	9.5M
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	-61.8M	-55.2M	-44.3M	-27M	-58.6M	-181.3M	-159.2M	0.0	0.0	0.0	108.5M	0.0	0.0	0.0
Prepaids	135.1M	173.7M	304.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1M	20.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	0.0	0.0	0.0	1.3B	938.1M	625.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4M	4,102.8B	3.5B
Total Current Assets	1.3B	1.4B	1.7B	4.5B	4B	4.5B	1.1B	436M	257.8M	324.6M	244.8M	150.3M	120.8M	166.6M	227.5M	62.7M	169.8M	94.2M	4,102.9B	29.3M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	0.0	0.0	0.0	11.8B	10.1B	7B	4.5B	4.9B	3.7B	2.8B	1.9B	1.6B	1.1B	1.1B	1.1B	1.1B	1.1B	820.2M	651.1M	371.2M
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6B
Intangible Assets	0.0	0.0	0.0	1.3B	1.2B	556.7M	403.1M	443.1M	296.2M	257M	108.9M	90.5M	52.8M	43.1M	35M	48.6M	52.8M	43.4M	15,787.6B	5.1B
Goodwill & Intangible Assets	0.0	0.0	0.0	1.3B	1.2B	556.7M	403.1M	443.1M	296.2M	257M	108.9M	90.5M	52.8M	43.1M	35M	48.6M	52.8M	43.4M	15,787.6B	27.8B
Long-Term Investments	1.6B	3.3B	2.9B	2.4B	1.1B	927M	520.1M	288.4M	177.4M	129.3M	47.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	8.8B	9B	6.4B	-2.8B	-1.9B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	11.4B	13.7B	15B	450.4M	416.2M	1.5B	-6.4B	-6.1B	-4.5B	4.9B	3.4B	1B	916.9M	283.6M	-35M	75.3M	-52.8M	93.9M	-19,890.4B	-27.7B
Total Non-Current Assets	13B	16.9B	17.9B	16B	12.8B	10B	7.8B	8.6B	6.2B	5.3B	3.5B	2.8B	2.1B	1.5B	1.1B	1.2B	1.1B	957.4M	-4,102.1B	471.9M
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.0	-243.8K	0.0	0.0	0.0
Total Assets	14.3B	18.3B	19.7B	20.5B	16.8B	14.5B	8.8B	9B	6.4B	5.6B	3.7B	2.9B	2.2B	1.6B	1.3B	1.3B	1.3B	1.1B	744.8M	501.2M
LIABILITIES
CURRENT LIABILITIES
Total Payables	0.0	0.0	0.0	603.6M	387.5M	285.9M	204.3M	211.2M	207.7M	134.5M	106.6M	85.3M	125M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accounts Payable	0.0	0.0	0.0	603.6M	387.5M	285.9M	246.7M	211.2M	174.6M	134.5M	106.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3M	81.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Short Term Debt	361.7M	1.5B	929.6M	4.2M	51.3M	5.6M	0.0	0.0	320K	125.3M	593.5M	265K	11.2K	39.8M	370M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	29.4M	38M	27.7M	0.0	0.0	0.0	13.5M	18.2M	19.9M	29.4M	27.2M	23.8M	20.6M	23.3M	23.1M	15.4M	16.1M	20.8M	14,615.6B	-5.6B
Other Current Liabilities	454.2M	412.2M	621.3M	0.0	0.0	0.0	28.1M	840.8M	-208M	-259.8M	-614.7M	8.4M	-125M	-39.8M	-716.8M	29.2M	38.4M	37.2M	0.0	-5.1B
Total Current Liabilities	845.4M	2B	1.6B	607.8M	438.8M	291.5M	217.8M	229.4M	227.6M	166.7M	139.8M	118.1M	86.6M	74.4M	405.9M	44.6M	54.5M	58M	52.9M	44.4M
NON-CURRENT LIABILITIES
Long Term Debt	8.5B	8.5B	9.3B	11.3B	8.9B	7B	4B	4.1B	2.6B	2.2B	1.6B	1.3B	0.0	0.0	344.4M	576.7M	630.6M	480.5M	305M	65M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	13.5M	18.2M	19.9M	29.4M	27.2M	23.8M	20.6M	0.0	23.1M	0.0	0.0	20.8M	14.6M	10.9M
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	-41M	-75.2M	-48.3M	-42.2M	-51M	-44.4M	-38M	0.0	-20.2M	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	0.0	0.0	0.0	96.4M	89M	45.7M	0.0	840.8M	290M	1.1B	620.7M	105M	1.1B	741M	81.7M	0.0	0.0	-20.8M	-319.6M	-65M
Total Non-Current Liabilities	8.6B	8.7B	9.5B	11.5B	9B	7.1B	4.1B	5B	2.9B	3.3B	2.2B	1.4B	1B	718.6M	43.3M	593.7M	638.4M	480.5M	348.1M	100.5M
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	-243K	-114.9K	-1M	-2.2M
Capital Lease Obligations	129M	156.6M	146.1M	87.2M	91.9M	78.3M	27.5M	57.1M	28.3M	12.8M	23.8M	20.6M	17.3M	0.0	20.2M	17M	13.6M	0.0	0.0	18.3B
Total Liabilities	9.5B	10.7B	11.1B	12.1B	9.5B	7.4B	4.3B	5.2B	3.2B	3.5B	2.4B	1.6B	1.1B	793.1M	449.2M	638.3M	692.6M	538.4M	400M	142.7M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	-777K	-777K	-777K	-777K	-262K	-262K	-262K	-262K	-262K	-262K	-262K	-262K	-262K	-262.3K	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	202K	49K	0.0	0.0	0.0	0.0	481.8K	231K	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	600K	599K	597K	597K	541K	518K	371K	364K	321K	237K	172.7K	161.3K	136.3K	111K	110.2K	78.7K	65.1K	52.1K	39.6K	39.3K
Additional Paid-In Capital	8.6B	8.6B	8.5B	8.6B	7.5B	7B	4.4B	4.3B	3.8B	2.6B	1.8B	1.6B	1.3B	1.1B	1.1B	759.7M	686.2M	540.5M	356.7M	359.6M
Retained Earnings	-3.7B	-971.8M	116.3M	-87.7M	0.0	83M	162.8M	-485.9M	-434.1M	-418.7M	-361.3M	-264.8M	-233.5M	-214.1M	-148.5M	-88.1M	-56.7M	-27.2M	-13M	-3.4M
Accumulated Other Comprehensive Income/Loss	-94.3M	42.5M	-59.2M	-36.7M	-122.7M	-62.9M	-58.2M	-26M	-92.9M	-72.9M	-21.9M	-8.9M	-12.5M	-12.2M	-3.6M	-60.3M	-40.3M	-22.7M	-10.8M	-5.3M
Other Total Stockholders' Equity	0.0	0.0	0.0	-1.0	-1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-7.7M	0.0	0.0	0.0
Total Stockholders' Equity	4.8B	7.6B	8.6B	8.4B	7.3B	7B	4.5B	3.8B	3.2B	2.1B	1.4B	1.3B	1B	828.8M	899.5M	671.4M	618.4M	513.1M	343.7M	356.3M
Total Equity	4.8B	7.6B	8.6B	8.4B	7.3B	7B	4.6B	3.8B	3.3B	2.1B	1.4B	1.3B	1B	828.8M	899.6M	671.6M	618.6M	513.2M	344.8M	358.5M
Minority Interest	1.1M	2.3M	1.6M	5.5M	5.3M	107K	13.8M	14.6M	4.9M	5M	0.0	0.0	0.0	0.0	114.2K	130.9K	243.3K	77.6K	1.1M	2.2M
SUMMARY
Total Liabilities & Equity	14.3B	18.3B	19.7B	20.5B	16.8B	14.5B	8.8B	9B	6.4B	5.6B	3.7B	2.9B	2.2B	1.6B	1.3B	1.3B	1.3B	1.1B	744.8M	501.2M
Total Investments	1.6B	3.3B	2.9B	2.4B	1.1B	927M	520.1M	288.4M	177.4M	129.3M	47.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	9B	10.2B	10.4B	11.4B	9B	7.1B	4.1B	5B	2.9B	3.3B	2.2B	1.4B	1B	689.8M	390.1M	593.7M	652M	480.5M	305M	100.5M
Net Debt	8.6B	10B	10.2B	10.9B	8.5B	5.6B	3.2B	4.8B	2.9B	3.1B	2.1B	1.4B	1B	587.1M	291.7M	578.4M	640.3M	386.3M	300.9M	41.4M
Shares Outstanding	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000	601,500,000

SEC Filings

MPW - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	January 20, 2026	January 20, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 07, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 30, 2025	October 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 14, 2025	August 11, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 11, 2025	August 11, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 08, 2025	June 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	July 31, 2025	July 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	June 03, 2025	May 29, 2025	2025	View Filing
10-Q 10-Q 2025 Q1 Q1	May 09, 2025	March 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	May 01, 2025	May 01, 2025	2025	View Filing

Showing 1 to 10 of 385 filings

Related Guides

Blog Categories

Continue your MPW research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.